Reply to "Clinically accessible biomarkers to assess the modifiable risk of asthma/wheezing attacks in toddlers"
J Allergy Clin Immunol Pract
.
2023 Jun;11(6):1985-1986.
doi: 10.1016/j.jaip.2023.03.027.
Authors
Anne M Fitzpatrick
1
,
David T Mauger
2
Affiliations
1
Department of Pediatrics, Emory University, Atlanta, Ga; Division of Pulmonary Medicine, Children's Healthcare of Atlanta, Atlanta, Ga. Electronic address: anne.fitzpatrick@emory.edu.
2
Department of Statistics, Pennsylvania State University, Hershey, Pa.
PMID:
37295868
DOI:
10.1016/j.jaip.2023.03.027
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Asthma* / diagnosis
Asthma* / epidemiology
Biomarkers
Child, Preschool
Humans
Respiratory Sounds*
Substances
Biomarkers
Grants and funding
R01 NR017939/NR/NINR NIH HHS/United States
K24 NR018866/NR/NINR NIH HHS/United States
UL1 TR002378/TR/NCATS NIH HHS/United States